Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20241214064051N4Phase 3Completed
Phase 3 trial of ketamine in Post-extubation sore throat (POST), sponsored by Babol University of Medical Sciences. Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20241214064051N4.